Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medlive Technology CoHKSE:02192 +0.90%90 Interest Coverage is 444.78 as of Dec. 2025, which is 203% above its 10-year median of 146.61. GuruFocus rates HKSE:02192 with a GF Score™ of 90/100 and a GF Value™ of HK$14.95 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 450 Healthcare Providers & Services companies, Medlive Technology Co ranks better than 89.78% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Medlive Technology Co's
Operating Income
for the
six
months ended in Dec. 2025 was HK$106.7 Mil. Medlive Technology Co's Interest Expense for the
six
months ended in Dec. 2025 was HK$-0.2 Mil.
Medlive Technology Co's interest coverage for the quarter that ended in Dec. 2025 was 444.78.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Medlive Technology Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for Medlive Technology Co's Interest Coverage or its related term are showing as below:
HKSE:02192'
s Interest Coverage Range Over the Past 10 Years
Min: 37.98 Med: 146.61 Max: 495.01
Current: 312.91
HKSE:02192's Interest Coverage is ranked better than 89.78% of 450
companies
in the Healthcare Providers & Services industry
Industry Median: 7.885
vs HKSE:02192: 312.91
Medlive Technology Co (HKSE:02192) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Medlive Technology Co Interest Coverage Related Terms
Medlive Technology Co Interest Coverage Historical Data
* Premium members only.
The historical data trend for Medlive Technology Co's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
HKSE:02192 vs VEEV, BTSG, HQY: Interest Coverage Comparison
For the Health Information Services subindustry, Medlive Technology Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medlive Technology Co Interest Coverage vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medlive Technology Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Medlive Technology Co's Interest Coverage falls into.
Medlive Technology Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medlive Technology Co (HKSE:02192) has a Interest Coverage of 444.78 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Medlive Technology Co and its competitors. This is 203% above median its historical median of 146.61. Over the past decade, Medlive Technology Co's Interest Coverage has ranged from 37.98 to 495.01. According to the industry distribution chart, Medlive Technology Co ranks #46 out of 450 companies in the Healthcare Providers & Services industry, placing it in the top 10.2%.
Is Medlive Technology Co's Interest Coverage too high?
Medlive Technology Co's current Interest Coverage of 444.78 is 203% above median its 10-year median of 146.61. Over the past 10 years, this metric has ranged from a low of 37.98 to a high of 495.01. The Healthcare Providers & Services industry median Interest Coverage is 7.89. Medlive Technology Co's value of 444.78 is 5540.8% above this industry median. Based on the distribution chart, Medlive Technology Co ranks #46 out of 450 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Medlive Technology Co has a GF Score™ of 90/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medlive Technology Co's Interest Coverage compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Medlive Technology Co ranks #46 out of 450 companies for Interest Coverage. This places Medlive Technology Co in the top 10% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 7.89. Medlive Technology Co's value of 444.78 is 5540.8% above this benchmark. Historically, Medlive Technology Co's own Interest Coverage has ranged from 37.98 to 495.01 over the past decade. While the company's 10-year median is 146.61 vs. the industry median of 7.89, Medlive Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Healthcare Providers & Services company?
The median Interest Coverage among Healthcare Providers & Services companies is 7.89, based on 450 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medlive Technology Co's current Interest Coverage of 444.78 is 5540.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Medlive Technology Co and its competitors. For the Healthcare Providers & Services industry, the median Interest Coverage is 7.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medlive Technology Co's current Interest Coverage is 444.78, which is 203% above median its own 10-year median of 146.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medlive Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Medlive Technology Co (HKSE:02192) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$14.95, compared to a current price of HK$7.87 — trading 47.4% below its estimated fair value. The current Interest Coverage is 444.78, which is 203% above median its 10-year median of 146.61 and 5540.8% above the Healthcare Providers & Services industry median of 7.89. Medlive Technology Co's overall GF Score™ is 90/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Medlive Technology Co (HKSE:02192), the current Interest Coverage is 444.78 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medlive Technology Co (HKSE:02192) Overvalued in 2026?
Based on GuruFocus' analysis, Medlive Technology Co stock appears to be undervalued.
The current stock price of HK$7.87 is trading 47.4% below its estimated GF Value™ of HK$14.95.
GuruFocus considers Medlive Technology Co to be Significantly Undervalued.
Key valuation signals for HKSE:02192:
Interest Coverage: 444.78 (203% above median its 10-year median of 146.61)
GF Value™: HK$14.95 vs. price of HK$7.87 (47.4% below fair value)
Industry Position: 5540.8% above the Healthcare Providers & Services median (#46 of 450)
No single metric tells the full story. See the HKSE:02192 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medlive Technology Co Ltd is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms. The company developed into a professional provider of medical information services and precision digital marketing services. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and a SaaS solution that helps with medical conferences and clinical research.
90GF Score
Get the complete analysis for HKSE:02192
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02192 has been successfully added to your 
